Financials
- Market Capitalization 108.47 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.86
Relación precio/flujo de caja
-167.18
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3812 | COYA Coya Therapeutics, Inc. - Common Stock | 4.81 USD | -2.83% | -1.03% | +9.57% | -18.75% | 112.83 M USD | ||
| 3813 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 4.05 USD | -1.46% | -3.57% | -23.15% | -37.79% | 112.81 M USD | ||
| 3830 | HUMA Humacyte, Inc. - Common Stock | 0.39 USD | -4.88% | -22.00% | -29.09% | -77.33% | 108.34 M USD | ||
| 3835 | VANI Vivani Medical, Inc. - Common Stock | 1.19 USD | -4.80% | -4.03% | -5.56% | -11.85% | 107.34 M USD |